Lifeward Stock Plunges 29.75% Amid Market Volatility

On June 25, 2025, Lifeward's stock experienced a significant drop of 29.75% in pre-market trading, reflecting a challenging market environment for the company.

Lifeward's stock has recently touched a 52-week low, indicating market challenges and investor concerns. This decline comes amidst broader market volatility and specific issues facing the company.

An Administrative Law Judge has determined that ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare beneficiaries. This ruling could have positive implications for Lifeward, as it validates the medical necessity of their product, potentially boosting investor confidence and future sales.